SGLT2 inhibitors (empagliflozin, dapagliflozin): act on the kidney
Impact of Cardiovascular Complications Among Patients With Type 2 Diabetes Mellitus: A Systematic Review
Features: Encourages optimal muscle function and recovery
And so, for me it was like, "Oh, this is just this wonderful tool that's such a needle mover." [00:25:05] And I firmly believe and I'm getting confirmation from other clinicians on this as well, and this is pretty well known in the space of longevity medicine and doctors who are using this peptide for some time is that the dose really makes the poison
The problem is that slowing may last for years, even after stopping semaglutide
Furthermore, a benefit/risk tool has been developed on the basis of current available evidence and guidelines to support primary care clinicians in selecting individuals who are most likely to benefit from GLP-1 RA therapies, in addition to indicating clinical situations where caution is needed